Detail akcie Mesa Lab online

Business Summary: Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. It also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. It has manufacturing operations in the United States and Europe.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, Mesa Laboratories Inc revenues increased 11% to $241M. Net loss decreased 99% to $2M. Revenues reflect Sterilization and Disinfection Control segment increase of 24% to $93.4M, Biopharmaceutical Development segment increase of 20% to $48.7M, Other segment increase of 17% to $99.1M, United States segment increase of 10% to $116.6M.